Brachio Basilic Arterio Venous Fistula One Stage vs Two Stage
Launched by ASSIUT UNIVERSITY · Mar 22, 2024
Trial Information
Current as of July 09, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at two different surgical methods for creating a type of access point for dialysis called a brachiobasilic arteriovenous fistula (BBAVF). The study aims to compare the success rates of these two methods: a one-stage approach, where the fistula is created in one surgery, and a two-stage approach, where it is done in two separate surgeries. Researchers want to find out which method works better in terms of how well the fistula functions over time.
To participate in the trial, patients must have end-stage renal disease and meet specific criteria, such as having a certain size for their arteries and veins as measured by ultrasound. Participants need to be able to give their consent and commit to attending follow-up visits. This trial is not yet recruiting, so no patients are currently enrolled, but it aims to help improve the way dialysis access is created for future patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • All patients with end-stage renal disease who had their BBAVFs created either by the one-stage or two- stage technique.
- • Patients with brachial artery diameter more than 3 . mm by duplex ultrasound (DUS).
- • Patients with triphasic brachial artery by DUS.
- • Patients with basilic vein diameter more than 3 mm by DUS.
- • Patients who were able to give informed consent.
- • Requirements for intervention agreement between the patient and the surgeon.
- • Availability of patients for all follow-up visits.
- Exclusion Criteria:
- • Patients who already had a suitable cephalic vein for arteriovenous fistula creation.
- • Patients whose brachial artery diameter was less than 3 mm by DUS.
- • Patients with brachial artery disease proved by DUS.
- • Patients whose basilic vein diameter was less than mm by DUS.
- • Patients with ischemic cardiomyopathy.
- • Patients with central venous stenosis or occlusion evidenced by duplex scanning.
- • Patients with flexion deformity or skin lesions at the site of the fistula or over the course of the vein.
About Assiut University
Assiut University, a prominent academic institution located in Egypt, is dedicated to advancing medical research and clinical trials that enhance healthcare outcomes. With a strong emphasis on innovation and collaboration, the university engages in a wide array of clinical studies across various disciplines, aiming to contribute valuable insights into disease prevention, diagnosis, and treatment. Assiut University's commitment to ethical research practices and rigorous scientific methodology ensures the integrity and reliability of its clinical trials, ultimately benefiting both the local community and the global medical landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Haitham A Hasan, Professor
Study Chair
Assiut University
Ahmed Kh Sayed, Lecturer
Study Director
Assiut University
Wael A Abdelgawad, Lecturer
Principal Investigator
Al-Azhar University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported